Quirem Medical is an emerging medical device company with a mission to develop the next generation microspheres for targeted interventional treatment of liver malignancies.
The unique properties of our Holmium based particles, QuiremSpheres™, provide for a more effective radioembolisation treatment. The imaging & dose quantification possibilities that the particles provide by use of both SPECT and MRI, enable the most accurate treatment planning and evaluation.
Quirem Medical has the ambition to provide a real-time, image guided, personalized radioembolisation treatment with improved patient outcome and lower hurdles for adoption of this innovative technology.
Holmium based particles, QuiremSpheres™